The Carbon to Value Initiative kicked off last week at Greentown Houston. Photo via GreentownLabs.com

A carbon innovation initiative in collaboration with Greentown Houston has named its new cohort.

The Carbon to Value Initiative (C2V Initiative) — a collaboration between NYU Tandon School of Engineering's Urban Future Lab (UFL), Greentown Labs, and Fraunhofer USA — has named nine startup participants for the fourth year of its carbontech accelerator program.

"Once again, the C2V Initiative has been able to select some of the most promising carbontech startups through a very competitive process with a 7 percent acceptance rate," Frederic Clerc, director of the C2V Initiative and interim managing director of UFL, says in a news release. "The diversity of this cohort, in its technologies, products, geographies, and stages, makes it an amazing snapshot of the rapidly evolving carbontech innovation landscape."

The cohort was selected from over a hundred applications from nearly 30 countries. In the six-month program, the nine companies gain access to the C2V Initiative's Carbontech Leadership Council, an invitation-only group of corporate, nonprofit, and government leaders who provide commercialization opportunities and identify avenues for technology validation, testing, and demonstration.

The year four cohort, according to the release, includes:

  • Ardent, from New Castle, Delaware, is a process technology company that is developing membrane-based solutions for point-source carbon capture and other chemical separations.
  • CarbonBlue, from Haifa, Israel, develops a chemical process that mineralizes and extracts CO2 from water, which then reabsorbs more atmospheric CO2.
  • MacroCycle, from Somerville, Massachusetts, develops a chemical recycling process to turn polyethylene terephthalate (PET) and polyester-fiber waste into "virgin-grade" plastics.
  • Maple Materials, from Richmond, California,develops an electrolysis process to convert CO2 into graphite and oxygen.
  • Oxylus Energy, from New Haven, Connecticut, develops a direct electrochemical process to convert CO2 into fuels and chemical feedstocks, such as methanol.
  • Phlair, from Munich, Germany, develops a renewable-energy-powered Direct Air Capture (DAC) system using an electrochemical process for acid and base generation.
  • Secant Fuel, from Montreal, Quebec, Canada, develops a one-step electrocatalytic process that converts flue gas into syngas.
  • RenewCO2, from Somerset, New Jersey, is developing an electrochemical process to convert CO2 into fuels and chemicals, such as sustainable aviation fuel (SAF) or propylene glycol.
  • Seabound, from London, England, builds carbon-capture equipment for new and existing ships.

"The depth and breadth of carbontech innovations represented in this applicant pool speaks volumes to this growing and dynamic industry around the world," adds Kevin Dutt, Interim CEO of Greentown Labs. "We're eager to support these nine impressive companies as they progress through this program and look forward to seeing how they engage with the CLC now and into the future."

The C2V Initiative kicked off at a public event on Sept. 19 at Greentown Houston and via livestream.

------

This article originally ran on EnergyCapital.

A new six-month accelerator program is looking to move the needle on the energy transition. Photo via greentownlabs.com

Houston organizations team up to accelerate startups with low-carbon solutions

greentown hou

Attention, innovators: A new initiative in Houston is searching for startups whose offerings can help reduce global carbon emissions.

The Low-Carbon Hydrogen Accelerator is a partnership involving Greentown Labs, the Electric Power Research Institute, Shell Oil, the City of Houston, and New York University's Urban Future Lab. The accelerator is seeking applications from startups that are advancing low-carbon hydrogen production, enhancing hydrogen storage and distribution, or providing business models for management of hydrogen supply chains. Applications are due February 9, 2022.

"If we can improve the devices and processes that will be used to make, transport, and store clean hydrogen in the future, it can become a cost-competitive fuel. At the same time, these advances can improve the capacity factor of renewable generation, producing multiple economic and climate benefits," Pat Sapinsley, managing director of cleantech initiatives at the Urban Future Lab, says in a news release.

The six-month accelerator will enable startups to collaborate with the Electric Power Research Institute, utilities, and Shell on tech development, feasibility studies, pilot projects, and other low-carbon efforts.

The institute and Shell will provide startups two routes within the accelerate: a path for validation of their technology and a path for demonstration of their technology.

"Accelerating low-carbon hydrogen technologies is essential to achieving global net-zero targets by 2050," says Neva Espinoza, the institute's vice president of energy supply and low-carbon resources.

Shell foresees hydrogen playing a bigger role in hard-to-decarbonize sectors such as heavy-duty trucking, marine, aviation, chemicals, steel, and cement. Julie Ferland, vice president of innovation excellence at Houston-based Shell Oil, says programs such as the new accelerator will be critical to fostering low-carbon energy.

Earlier this year, after visiting Greentown Labs' Houston location, U.S. Energy Secretary Jennifer Granholm and the U.S. Department of Energy launched the Hydrogen Energy Earthshot to reduce the cost of clean hydrogen by 80 percent to $1 per kilogram by 2030.

"As the Energy Capital of the World, I believe it is our responsibility to continue Houston's legacy of energy innovation and develop the technologies and practices needed to decarbonize the global energy sector," Houston Mayor Sylvester Turner says. "Houston has the skilled workforce and infrastructure to develop clean hydrogen at scale, and Greentown Labs' Low-Carbon Hydrogen Accelerator is a great example of the kind of partnerships we need to make it happen."

Greentown Labs is the largest climatech startup incubator in North America. The Somerville, Massachusetts-based incubator recently opened its Houston location.

Houston-based Cemvita Factory, which biomimics photosynthesis to turn carbon emissions into feedstock, has been selected for a new international accelerator. Photo courtesy of Cemvita Factory

Houston startup selected for international carbontech accelerator

the future of climatech

A new international accelerator focused on the commercialization of carbontech has announced its new cohort — and one Houston-based company has made the cut.

Cemvita Factory has been accepted into the Carbon to Value Initiative, a recently launched accelerator supported by The Urban Future Lab at the NYU Tandon School of Engineering, Greentown Labs, and Fraunhofer USA. The program is focused on supporting companies with technologies that capture, convert, and store carbon dioxide (CO₂) into valuable end products or services, according to a news release.

"In addition to being absolutely necessary to stave off dangerous climate impacts, carbontech innovations represent a potential $3 trillion market opportunity," says Pat Sapinsley, managing director at the Urban Future Lab, in the news release. "We are excited to welcome 10 startups, each proposing different business models and technology innovations to realize that opportunity."

Cemvita Factory, which was founded by siblings Tara and Moji Karimi in 2017, has created a way to biomimic photosynthesis to take CO2 and turn it into something usable for its energy clients, like feedstocks. Cemvita has 30 different molecules its technology can produce and works with the likes of BHP, Oxy, and more.

"We are excited to represent Houston in the first cohort for the Carbon to Value Initiative," Moji Karimi tells InnovationMap. "We want to send a message that Houston is not just the Oil and Gas capital of the world, but also the center of gravity for a sustainable Energy Transition."The C2V Initiative selected 10 startups out of over 130 applications from 26 countries. The cohort has technologies ranging from carbon utilization product and process innovations to carbon capture and carbon sequestration solutions.

Cemvita isn't alone in repping the Lone Star State. San Antonio-based CarbonFree, which has commercial technologies that capture and convert industrial CO2 emissions into minerals for sale or storage, also made the cohort.

The other eight non-Texas companies are:

  • Air Company, based in New York City, transforms CO2 into high-purity alcohols that can be used in spirits, sanitizers, and a variety of consumer industries.
  • Reykjavík, Iceland-based Carbfix provides a natural and permanent carbon storage solution by turning CO2 into stone underground.
  • CarbonQuest, based in New York City, provides decarbonization technologies and solutions for buildings with a focus on modular carbon capture.
  • Toronto, Canada-based CERT converts CO2 to chemicals such as ethylene via electrolysis.
  • Made of Air, based in Berlin, Germany creates drop-in ready, durable thermoplastics using carbon captured by biomass.
  • Oakland, California-based Mars Materials develops a new pathway for carbon fiber production using CO2 as a raw material.
  • San Francisco-based Patch is a platform for negative emissions.
  • Planetary Hydrogen, based in Dartmouth, Canada, combines hydrogen production with CO2 sequestration via ocean air capture.

The program kicks off at a virtual event on May 6 from 3-5 p.m. The six-month program will provide its cohort with a customized curriculum, hands-on mentorship, and knowledge-sharing sessions with C2V Initiative's Carbontech Leadership Council— an invitation-only group of international corporate, academic, and government thought leaders.

The cohort will also receive complimentary membership and access to the Greentown Labs community, which includes is recently opened facility in Houston.

"We know that to effectively address the climate crisis and mitigate the effects of climate change, we need to rapidly scale and deploy carbontech solutions to accelerate the energy transition," says Emily Reichert, CEO of Greentown Labs. "We're proud to support these startups from all over the world and look forward to the collaborations that will spark among the startups and our CLC members."

Listen to Cemvita Factory's episode of the Houston Innovators Podcast below.


Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston hospital names leading cancer scientist as new academic head

new hire

Houston Methodist Academic Institute has named cancer clinician and scientist Dr. Jenny Chang as its new executive vice president, president, CEO, and chief academic officer.

Chang was selected following a national search and will succeed Dr. H. Dirk Sostman, who will retire in February after 20 years of leadership. Chang is the director of the Houston Methodist Dr. Mary and Ron Neal Cancer Center and the Emily Herrmann Presidential Distinguished Chair in Cancer Research. She has been with Houston Methodist for 15 years.

Over the last five years, Chang has served as the institute’s chief clinical science officer and is credited with strengthening cancer clinical trials. Her work has focused on therapy-resistant cancer stem cells and their treatment, particularly relating to breast cancer.

Her work has generated more than $35 million in funding for Houston Methodist from organizations like the National Institutes of Health and the National Cancer Institute, according to the health care system. In 2021, Dr. Mary Neal and her husband Ron Neal, whom the cancer center is now named after, donated $25 million to support her and her team’s research on advanced cancer therapy.

In her new role, Chang will work to expand clinical and translational research and education across Houston Methodist in digital health, robotics and bioengineered therapeutics.

“Dr. Chang’s dedication to Houston Methodist is unparalleled,” Dr. Marc L. Boom, Houston Methodist president and CEO, said in a news release. “She is committed to our mission and to helping our patients, and her clinical expertise, research innovation and health care leadership make her the ideal choice for leading our academic mission into an exciting new chapter.”

Chang is a member of the American Association of Cancer Research (AACR) Stand Up to Cancer Scientific Advisory Council. She earned her medical degree from Cambridge University in England and completed fellowship training in medical oncology at the Royal Marsden Hospital/Institute for Cancer Research. She earned her research doctorate from the University of London.

She is also a professor at Weill Cornell Medical School, which is affiliated with the Houston Methodist Academic Institute.

Texas A&M awarded $1.3M federal grant to develop clean energy tech from electronic waste

seeing green

Texas A&M University in College Station has received a nearly $1.3 million federal grant for development of clean energy technology.

The university will use the $1,280,553 grant from the U.S. Department of Energy to develop a cost-effective, sustainable method for extracting rare earth elements from electronic waste.

Rare earth elements (REEs) are a set of 17 metallic elements.

“REEs are essential components of more than 200 products, especially high-tech consumer products, such as cellular telephones, computer hard drives, electric and hybrid vehicles, and flat-screen monitors and televisions,” according to the Eos news website.

REEs also are found in defense equipment and technology such as electronic displays, guidance systems, lasers, and radar and sonar systems, says Eos.

The grant awarded to Texas A&M was among $17 million in DOE grants given to 14 projects that seek to accelerate innovation in the critical materials sector. The federal Energy Act of 2020 defines a critical material — such as aluminum, cobalt, copper, lithium, magnesium, nickel, and platinum — as a substance that faces a high risk of supply chain disruption and “serves an essential function” in the energy sector.

“DOE is helping reduce the nation’s dependence on foreign supply chains through innovative solutions that will tap domestic sources of the critical materials needed for next-generation technologies,” says U.S. Energy Secretary Jennifer Granholm. “These investments — part of our industrial strategy — will keep America’s growing manufacturing industry competitive while delivering economic benefits to communities nationwide.”

------

This article originally appeared on EnergyCapital.

Biosciences startup becomes Texas' first decacorn after latest funding

A Dallas-based biosciences startup whose backers include millionaire investors from Austin and Dallas has reached decacorn status — a valuation of at least $10 billion — after hauling in a series C funding round of $200 million, the company announced this month. Colossal Biosciences is reportedly the first Texas startup to rise to the decacorn level.

Colossal, which specializes in genetic engineering technology designed to bring back or protect various species, received the $200 million from TWG Global, an investment conglomerate led by billionaire investors Mark Walter and Thomas Tull. Walter is part owner of Major League Baseball’s Los Angeles Dodgers, and Tull is part owner of the NFL’s Pittsburgh Steelers.

Among the projects Colossal is tackling is the resurrection of three extinct animals — the dodo bird, Tasmanian tiger and woolly mammoth — through the use of DNA and genomics.

The latest round of funding values Colossal at $10.2 billion. Since launching in 2021, the startup has raised $435 million in venture capital.

In addition to Walter and Tull, Colossal’s investors include prominent video game developer Richard Garriott of Austin and private equity veteran Victor Vescov of Dallas. The two millionaires are known for their exploits as undersea explorers and tourist astronauts.

Aside from Colossal’s ties to Dallas and Austin, the startup has a Houston connection.

The company teamed up with Baylor College of Medicine researcher Paul Ling to develop a vaccine for elephant endotheliotropic herpesvirus (EEHV), the deadliest disease among young elephants. In partnership with the Houston Zoo, Ling’s lab at the Baylor College of Medicine has set up a research program that focuses on diagnosing and treating EEHV, and on coming up with a vaccine to protect elephants against the disease. Ling and the BCMe are members of the North American EEHV Advisory Group.

Colossal operates research labs Dallas, Boston and Melbourne, Australia.

“Colossal is the leading company working at the intersection of AI, computational biology, and genetic engineering for both de-extinction and species preservation,” Walter, CEO of TWG Globa, said in a news release. “Colossal has assembled a world-class team that has already driven, in a short period of time, significant technology innovations and impact in advancing conservation, which is a core value of TWG Global.”

Well-known genetics researcher George Church, co-founder of Colossal, calls the startup “a revolutionary genetics company making science fiction into science fact.”

“We are creating the technology to build de-extinction science and scale conservation biology,” he added, “particularly for endangered and at-risk species.”